Skip to main content

Find Clinical Trials

Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

NCT02692703

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C

NCT01674725

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection

NCT01767116

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

NCT02292719

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Chronic Hepatitis C Infection

NCT01716585

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

NCT02219503

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +16 more
Locations: Not specified

View Trial Details

Completed

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

NCT01939197

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +29 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection

NCT01833533

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

NCT01704755

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +17 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

NCT01995071

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details